0001062993-22-005202.txt : 20220222
0001062993-22-005202.hdr.sgml : 20220222
20220222213429
ACCESSION NUMBER: 0001062993-22-005202
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220218
FILED AS OF DATE: 20220222
DATE AS OF CHANGE: 20220222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Washer Susan B.
CENTRAL INDEX KEY: 0001598540
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36370
FILM NUMBER: 22660457
MAIL ADDRESS:
STREET 1: C/O APPLIED GENETIC TECHNOLOGIES CORP.
STREET 2: 11801 RESEARCH DRIVE, SUITE D
CITY: ALACHUA
STATE: FL
ZIP: 32615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: APPLIED GENETIC TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001273636
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 593553710
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 14193 NW 119TH TERRACE
STREET 2: SUITE #10
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: 386-462-2204
MAIL ADDRESS:
STREET 1: 14193 NW 119TH TERRACE
STREET 2: SUITE #10
CITY: ALACHUA
STATE: FL
ZIP: 32615
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-02-18
0001273636
APPLIED GENETIC TECHNOLOGIES CORP
AGTC
0001598540
Washer Susan B.
C/O APPLIED GENETIC TECHNOLOGIES CORP.
14193 NW 119TH TERRACE, SUITE #10
ALACHUA
FL
32615
1
1
0
0
President and CEO
Common Stock
2022-02-18
4
M
0
120686
0.35
A
152971
D
Common Stock
2022-02-18
4
S
0
9950
2.18
D
143021
D
Stock Option (right to buy)
0.35
2022-02-18
4
M
0
120686
0
D
2023-01-06
Common Stock
120686
0
D
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.15 to $2.22, inclusive.
Option is fully-vested and was exercisable for shares of common stock at any time until the expiration of the option at the holder's election.
The reporting person undertakes to provide to Applied Genetic Technologies Corporation, any security holder of Applied Genetic Technologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 above.
/s/ Stacie Aarestad, Attorney-in-fact
2022-02-22